PropertyValue
?:abstract
  • Chloroquine which was believed to be a great hope in the treatment of COVID-19 by many, has now been declared to be insufficient against the novel coronavirus It has not shown a significant improvement in patients\' health when it comes to clinical trial, despite the promising molecular mechanisms of Chloroquine which have been found to be anti-viral and anti-inflammatory Therefore, the hope is pinned even more on the drugs that are still part of the solidarity clinical trial of the WHO: Remdesivir (an inhibitor of the viral RNA polymerase) and the HIV medication Ritonavir/Lopinavir together with interferon beta being used against multiple sclerosis
is ?:annotates of
?:creator
?:journal
  • Internistische_Praxis
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • Chloroquine for treatment of COVID-19
?:type
?:who_covidence_id
  • #833785
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/4fz2tdj4>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/4fz2tdj4>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all